Fin d'année 29 Février 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -27.316 | 11.447 | 2.401 | -3.87 | -32.926 | 0.446 | -34.574 | -8.458 |
Return on Equity (%) | -45.812 | 17.755 | 3.618 | -5.886 | -54.748 | 0.784 | -60.837 | -15.922 |
Return on Invested Capital (%) | -13.823 | 10.912 | 2.157 | -4.425 | -20.27 | -0.06 | -18.556 | -12.365 |
Operating Margin (%) | -92.284 | 43.562 | 8.518 | -14.231 | -124.636 | 2.646 | -109.756 | -12.427 |
Net Profit Margin (%) | -92.131 | 43.455 | 10.288 | -14.615 | -123.628 | 1.671 | -111.89 | -15.24 |
Book Value Per Share | 1.625 | 2.645 | 0.187 | 0.311 | -0.2 | 0.321 | 0.099 | 0.1 |
Earnings Per Share | -2.187 | 0.734 | 0.165 | -0.267 | -1.902 | 0.02 | -1.229 | -0.217 |
Cash Per Share | 1.331 | 1.479 | 0.975 | 0.662 | 0.369 | 0.639 | 0.494 | 0.292 |
Working Capital Per Share | 1.988 | 3.778 | 1.286 | 0.132 | 0.994 | 1.093 | 0.023 | 0.253 |
Operating Profit Per Share | 1.119 | 2.453 | 1.465 | 1.457 | 1.108 | 1.149 | 0.933 | 0.866 |
EBIT Per Share | -2.191 | 0.736 | 0.137 | -0.26 | -1.918 | 0.032 | -1.206 | -0.177 |
EBITDA Per Share | -2.191 | 0.736 | 0.137 | -0.26 | -1.918 | 0.032 | -1.206 | -0.177 |
Free Cash Flow Per Share | -2.4 | 0.538 | 0.011 | -0.531 | -2.14 | -0.193 | -1.321 | -0.272 |
Fin d'année 29 Février 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | 2.765 | 5.491 | 2.418 | 1.067 | 2.345 | 2.627 | 1.019 | 1.427 |
Quick Ratio | 2.541 | 5.194 | 2.253 | 1.003 | 2.147 | 2.141 | 0.749 | 1.225 |
Inventory Turnover (Days) | 7.25 | 1.175 | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 530,5M | 536,73M | 547,36M | 554,2M | 565,51M | 576,23M | 582,16M | N/A |
Fin d'année 29 Février 2024 | Mai 2022 | Août 2022 | Nov 2022 | Fév 2023 | Mai 2023 | Août 2023 | Nov 2023 | Fév 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 577,17M | 577,42M | 580,35M | 582,16M | 583,24M | 583,68M | 585,34M | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | -105.952 | N/A | N/A | N/A | -2.145 | N/A | N/A | N/A |
Net Profit Margin (%) | -107.738 | N/A | N/A | N/A | -2.949 | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | 1.85 | N/A | N/A | N/A | 0.946 | N/A | N/A | N/A |
Quick Ratio | 1.468 | N/A | N/A | N/A | 0.86 | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 1,8B |
Ratio cours/bénéfice | -13,87 |
Ratio prix/ventes | 2,11 |
Ratio prix/liquidités | 10,3 |
Ratio prix/valeur comptable | 2,32 |
Rendement de dividende | - |
Actions en circulation | 589,23M |
Volume moyen (1 semaine) | 22,65M |
Volume moyen (1 mois) | 13,21M |
Variation sur 52 semaines | -52,11% |
Plus haut sur 52 semaines | 5,75 |
Plus bas sur 52 semaines | 2,22 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales